pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Jan 26, 2026

    50
    ›Jan 30, 2026approval212d agoLATANOPROST — FDA approvalXalatan

    Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Xalatan →fda approvals ↗
    ›Jan 30, 2026approval212d agoEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approvalemtricitabine

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →emtricitabine →fda approvals ↗
    ›Jan 30, 2026approval212d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval212d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval212d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval212d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval212d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 30, 2026approval212d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoLYBALVI (OLANZAPINE) — FDA approval(olanzapine + samidorphan l-malate)

    Sponsor: ALKERMES INC. Form: TABLET. Route: ORAL

    full page →(olanzapine + samidorphan l-malate) →fda approvals ↗
    ›Jan 30, 2026approval212d agoVENLAFAXINE HYDROCHLORIDE — FDA approvalViatris Inc

    Sponsor: PLATINUM. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoCETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalCETIRIZINE HYDROCHLORIDE

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 30, 2026approval212d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Jan 30, 2026approval212d agoOZEMPIC (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoENBREL (ETANERCEPT) — FDA approvalAMGEN INC

    Sponsor: IMMUNEX. Form: SYRINGE

    full page →fda approvals ↗
    ›Jan 30, 2026approval212d agoVALACYCLOVIR HYDROCHLORIDE — FDA approvalVALACYCLOVIR HYDROCHLORIDE

    Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL

    full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Jan 30, 2026grant212d agoGORDON RESEARCH CONFERENCES — 2026 Atomically Precise Nanochemistry Gordon Research Conference and Gordon R...

    EB grant. $7,140. PI: Stacy Marla Copp

    full page →nih reporter ↗
    ›Jan 30, 2026grant212d agoUNIVERSITY OF DELAWARE — Understanding linguistic differences in mild cognitive impairment: The import...

    AG grant. $46,086. PI: Anna Saylor

    full page →nih reporter ↗
    ›Jan 30, 2026grant212d agoUNIVERSITY OF PENNSYLVANIA — What interventions to reduce hospital nurse burnout are most effective?University of Pennsylvania

    NR grant. $1,422,387. PI: EILEEN T LAKE

    full page →nih reporter ↗
    ›Jan 31, 2026grant211d agoUNIVERSITY OF MINNESOTA — Paraventricular Nucleus of the Thalamus and Nucleus Accumbens Neurons in Aver...University of Minnesota

    AA grant. $78,520. PI: Meredith Rose Bauer

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF PENNSYLVANIA — Project 4: Chromatin basis of cellular senescence and tissue agingUniversity of Pennsylvania

    AG grant. $401,404. PI: Rugang Zhang

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoOHIO STATE UNIVERSITY — Energy balance, mTOR pathway signaling, and breast cancer prognosis

    CA grant. $766,371. PI: Ting-Yuan Cheng

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF VIRGINIA — Myeloid Cell Regulation of Cerebrovascular Basal and Functional ToneUniversity of Virginia

    NS grant. $242,250. PI: Ukpong Bassey Eyo

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Lympnoids tissue senescence and multimodal imaging using REDCATUniversity of California San Diego

    AG grant. $700,795. PI: VISHWA DEEP DIXIT

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Impact of Pathological Tau on Circuit Function in Phenotypic Mouse Models of ...University of California San Francisco

    NS grant. $136,620. PI: Rose Berthe Creed

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoMEDICAL COLLEGE OF WISCONSIN — p66Shc in Cerebrovascular Impairment in Alzheimer’s Disease

    AG grant. $441,460. PI: Fan Fan

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoDUKE UNIVERSITY — Defining cellular and molecular signatures of inflammation in people with sup...Duke University

    DK grant. $832,783. PI: Todd Christopher Bradley

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoWEST VIRGINIA UNIVERSITY — Tubulinopathy and visual disorders

    GM grant. $243,046. PI: Eric James Horstick

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Clinical, Anatomic, and Pathologic Spread of Semantic Language Impairment in ...Northwestern University

    AG grant. $49,538. PI: Allegra Kawles

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoSOUTH DAKOTA STATE UNIVERSITY — Defining the function of spatiotemporal JNK activation in cell fate determina...

    GM grant. $264,270. PI: Ryan L Hanson

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIV OF ARKANSAS FOR MED SCIS — Roles of Hsp47 in breast cancer progression

    CA grant. $267,208. PI: Ren Xu

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoOREGON HEALTH & SCIENCE UNIVERSITY — Development of Long-Acting Antiretroviral Therapy for Sustained SIV Suppressi...

    AI grant. $482,625. PI: Jonah B. Sacha

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF KENTUCKY — Evaluation of Noninvasive Muscle Imaging Biomarkers for Knee Osteoarthritis i...

    AG grant. $666,504. PI: Christopher Fry

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Cholesterol Metabolism in Regulatory T cell FunctionUniversity of Utah

    AI grant. $423,500. PI: Maria Bettini

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoKEYSTONE SYMPOSIA — Aging: Immune Function and Organ Health

    AG grant. $19,600. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoBROWN UNIVERSITY — Brown Moi Partnership for Biostatistics Training in HIV-NAMBARI

    TW grant. $185,185. PI: JOSEPH W HOGAN

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoBRIGHAM AND WOMEN'S HOSPITAL — Quantifying integrase resistance among Nigerian children failing dolutegravir...Brigham and Women's Hospital

    AI grant. $51,600. PI: Barry Ryan Lutz

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Mitochondrial lateral transfer during metastasisUniversity of Utah

    CA grant. $352,275. PI: Minna Roh

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoHARVARD MEDICAL SCHOOL — Investigation of factors involved in assembly of the mycolata envelope

    AI grant. $80,224. PI: Anastacia R Parks

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — PHARMA-GIRL: Empowering adolescent girls and young women with choice and prev...University of California San Francisco

    HD grant. $151,482. PI: Lila A Sheira

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoJOHNS HOPKINS UNIVERSITY — A Deep Learning-based Miniature Microscope for Imaging Aging and Alzheimer's ...Johns Hopkins University

    AG grant. $618,410. PI: Danapala M. M. Janaka Senarathna

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF WISCONSIN-MADISON — Orthobiologics for Sports Medicine Physicians: Bridging the Gaps

    AR grant. $15,000. PI: Stephanie Kliethermes

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoMASSACHUSETTS GENERAL HOSPITAL — Non-Invasive Vagus Nerve Stimulation in Subarachnoid HemorrhageMassachusetts General Hospital

    NS grant. $511,402. PI: Cenk Ayata

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Improving Hormone Therapy Use in Patients with Premature or Early Menopause

    AG grant. $552,154. PI: Jason Wright

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in You...New York University

    NS grant. $247,995. PI: Nicolas Julian Abreu

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF COLORADO DENVER — SMART-2D: Study of Montelukast's Effects on Renal and Cardiovascular Health i...University of Colorado Denver

    DK grant. $193,075. PI: Angelina Dixon

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Structural and molecular mechanisms of CRAC channel gatingNorthwestern University

    AI grant. $739,353. PI: Murali Prakriya

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF VIRGINIA — The Profibrotic Effects of Hematopoietic Y Chromosome Loss in HFpEFUniversity of Virginia

    AG grant. $689,148. PI: KENNETH WALSH

    full page →nih reporter ↗
    ›Feb 1, 2026grant210d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Cytomegalovirus, midlife inflammation, and subclinical cardiovascular disease...

    AG grant. $127,710. PI: Aleda Leis

    full page →nih reporter ↗
    ← prev
    page 417 of 475
    next →
    $TEVA36.44-3.14%
    $ALKS47.41-3.05%
    $VTRS16.34-3.26%
    $AMGN432.42-1.05%